APEX is a prospective multi-site registry of real-world experience with the Optilumeā¢ BPH Catheter System for treatment of men experiencing symptomatic BPH.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The primary efficacy endpoint is the average IPSS change from baseline to 12 months.
Timeframe: Baseline to 12 months
The primary safety endpoint is the freedom from treatment-related adverse SAEs.
Timeframe: Baseline to 12 months